©The Author(s) 2025.
World J Psychiatry. Sep 19, 2025; 15(9): 108382
Published online Sep 19, 2025. doi: 10.5498/wjp.v15.i9.108382
Published online Sep 19, 2025. doi: 10.5498/wjp.v15.i9.108382
Table 6 Natural monomers modulating the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 pathway to mitigate hepatocellular carcinoma
| Monomers | Disease models | Mechanisms | Role | Ref. |
| Curcumin | HCC | Reduces oxidative damage and inflammation | Improve | Khalil et al[178] |
| Resveratrol | HCC | Against oxidative stress | Improve | Amirshahrokhi and Niapour[179] |
| Berberine | HCC | Reduces hepatic triglyceride accumulation and oxidative stress | Improve | Bellaver et al[181] |
| Tanshinone IIA | HCC | Reduces oxidative stress markers and enhances antioxidant defenses | Improve | Zhao et al[182] |
| Ginsenosides | HCC | Inhibits inflammasomes | Improve | Gao et al[183] |
| Brusatol | HCC | Mediates ferroptosis | Improve | Görg et al[184] |
| Oleanolic acid oxime derivatives | HCC | Reduces cell cycle, apoptosis, and proliferation | Improve | Navarro and Esteras[185] |
| Emodin | HCC | Suppresses cell proliferation, invasion, and angiogenesis | Improve | Wang et al[186] |
- Citation: Zhang YM, Zhang ZG. Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders. World J Psychiatry 2025; 15(9): 108382
- URL: https://www.wjgnet.com/2220-3206/full/v15/i9/108382.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i9.108382